Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 289

1.

Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization.

Jacobs TW, Pliss N, Kouria G, Schnitt SJ.

Am J Surg Pathol. 2001 Feb;25(2):229-36.

PMID:
11176072
[PubMed - indexed for MEDLINE]
2.

Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis.

Maluf HM, Swanson PE, Koerner FC.

Am J Surg Pathol. 2001 Feb;25(2):237-44.

PMID:
11176073
[PubMed - indexed for MEDLINE]
3.

Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.

Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP.

Mod Pathol. 2002 Oct;15(10):1044-50.

PMID:
12379750
[PubMed - indexed for MEDLINE]
Free Article
4.

Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.

Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ.

Am J Clin Pathol. 2001 Jan;115(1):85-98.

PMID:
11190811
[PubMed - indexed for MEDLINE]
Free Article
5.

Heterogeneous expression of nm23 gene product in noninvasive breast carcinoma.

Simpson JF, O'Malley F, Dupont WD, Page DL.

Cancer. 1994 May 1;73(9):2352-8.

PMID:
7513249
[PubMed - indexed for MEDLINE]
6.

Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.

Moll R, Mitze M, Frixen UH, Birchmeier W.

Am J Pathol. 1993 Dec;143(6):1731-42.

PMID:
8256859
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The ductal phenotypic expression of the E-cadherin/catenin complex in tubulolobular carcinoma of the breast: an immunohistochemical and clinicopathologic study.

Esposito NN, Chivukula M, Dabbs DJ.

Mod Pathol. 2007 Jan;20(1):130-8. Epub 2006 Nov 24.

PMID:
17143261
[PubMed - indexed for MEDLINE]
Free Article
8.

Biological profile of in situ breast cancer investigated by immunohistochemical technique.

Albonico G, Querzoli P, Ferretti S, Rinaldi R, Nenci I.

Cancer Detect Prev. 1998;22(4):313-8.

PMID:
9674874
[PubMed - indexed for MEDLINE]
9.

Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.

Ottesen GL.

APMIS Suppl. 2003;(108):1-67. Review.

PMID:
12874968
[PubMed - indexed for MEDLINE]
10.

Cadherin-catenin complex dissociation in lobular neoplasia of the breast.

Morrogh M, Andrade VP, Giri D, Sakr RA, Paik W, Qin LX, Arroyo CD, Brogi E, Morrow M, King TA.

Breast Cancer Res Treat. 2012 Apr;132(2):641-52. doi: 10.1007/s10549-011-1860-0. Epub 2011 Nov 13.

PMID:
22080244
[PubMed - indexed for MEDLINE]
11.

Mammographically detected in situ lobular carcinomas of the breast.

Sapino A, Frigerio A, Peterse JL, Arisio R, Coluccia C, Bussolati G.

Virchows Arch. 2000 May;436(5):421-30.

PMID:
10881735
[PubMed - indexed for MEDLINE]
12.

Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias.

Bratthauer GL, Moinfar F, Stamatakos MD, Mezzetti TP, Shekitka KM, Man YG, Tavassoli FA.

Hum Pathol. 2002 Jun;33(6):620-7.

PMID:
12152161
[PubMed - indexed for MEDLINE]
13.

E-cadherin reactivity of 95 noninvasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions.

Goldstein NS, Bassi D, Watts JC, Layfield LJ, Yaziji H, Gown AM.

Am J Clin Pathol. 2001 Apr;115(4):534-42.

PMID:
11293901
[PubMed - indexed for MEDLINE]
Free Article
14.

E-cadherin expression correlates with histologic type but not tumour grade in invasive breast cancer.

Nurismah MI, Noriah O, Suryati MY, Sharifah NA.

Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):699-702.

PMID:
19256762
[PubMed - indexed for MEDLINE]
Free Article
15.
16.

Interobserver variability and aberrant E-cadherin immunostaining of lobular neoplasia and infiltrating lobular carcinoma.

Choi YJ, Pinto MM, Hao L, Riba AK.

Mod Pathol. 2008 Oct;21(10):1224-37. doi: 10.1038/modpathol.2008.106. Epub 2008 Jun 27.

PMID:
18587329
[PubMed - indexed for MEDLINE]
Free Article
17.

Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.

Goldstein NS, Kestin LL, Vicini FA.

Cancer. 2001 Aug 15;92(4):738-47.

PMID:
11550142
[PubMed - indexed for MEDLINE]
18.

Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: A clinicopathologic study of 18 cases.

Fadare O, Dadmanesh F, Alvarado-Cabrero I, Snyder R, Stephen Mitchell J, Tot T, Wang SA, Ghofrani M, Eusebi V, Martel M, Tavassoli FA.

Am J Surg Pathol. 2006 Nov;30(11):1445-53.

PMID:
17063087
[PubMed - indexed for MEDLINE]
19.

P-cadherin expression is associated with high-grade ductal carcinoma in situ of the breast.

Paredes J, Milanezi F, Viegas L, Amendoeira I, Schmitt F.

Virchows Arch. 2002 Jan;440(1):16-21.

PMID:
11942571
[PubMed - indexed for MEDLINE]
20.

Lobular carcinoma in situ and infiltrating ductal carcinoma: frequent presence of DCIS as a precursor lesion.

Maluf H, Koerner F.

Int J Surg Pathol. 2001 Apr;9(2):127-31.

PMID:
11484500
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk